West Pharmaceutical Services Market Cap 2010-2024 | WST

West Pharmaceutical Services market cap history and chart from 2010 to 2024. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. West Pharmaceutical Services market cap as of February 21, 2025 is $14.64B.
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $14.641B $2.893B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $75.539B 20.67
Becton Dickinson (BDX) United States $65.341B 16.36
Cardinal Health (CAH) United States $30.619B 16.40
Straumann Holding AG (SAUHY) Switzerland $23.663B 0.00
Labcorp (LH) United States $20.727B 17.01
Cooper (COO) United States $17.256B 23.37
Align Technology (ALGN) United States $15.064B 28.62
Henry Schein (HSIC) United States $9.704B 18.49
Merit Medical Systems (MMSI) United States $6.202B 31.67
DENTSPLY SIRONA (XRAY) United States $3.773B 10.26
Patterson (PDCO) United States $2.741B 14.64
CONMED (CNMD) United States $1.948B 15.15
STAAR Surgical (STAA) United States $0.876B 0.00
Lifevantage (LFVN) United States $0.230B 25.50
Pro-Dex (PDEX) United States $0.112B 17.13